Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 3Breast Neoplasms 3Male Urogenital Diseases 2Small Cell Lung Carcinoma 1Polycystic Ovary Syndrome 1Lymphoma, Follicular 1Lymphedema 1Lung Neoplasms 1Head and Neck Neoplasms 1Fibrosis 1Erectile Dysfunction 1Drug-Related Side Effects and Adverse Reactions 1Crohn Disease 1Colorectal Neoplasms 1Colitis, Ulcerative 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Brain Neoplasms 1

Interventions

Pentoxifylline 3Tocopherols 2tremelimumab 1ruxolitinib 1maltodextrin 1durvalumab 1atezolizumab 1Vitamin E 1Sunitinib 1Standard of Care 1Specimen Handling 1Simvastatin 1Pravastatin 1Physical Therapy Modalities 1Pharmaceutical Preparations 1Magnetic Resonance Spectroscopy 1Losartan 1Liver Transplantation 1Ketoprofen 1Hyperbaric Oxygenation 1Bevacizumab 1Amino Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Fibrosis × Vitamin E × Clear all
NCT00583700 2013-01-29

Trental & Vitamin E for Radiation-Induced Fibrosis

University of Iowa

Phase 2 Completed
54 enrolled 7 charts
Breast

Breast Neoplasms, Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡